BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Suranjith L. Seneviratne, Anne Maitland, Lawrence Afrin. Mast cell disorders in Ehlers-Danlos syndromeAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics 2017; 175(1): 226 doi: 10.1002/ajmg.c.31555
Milda Vysniauskaite, Hans-Jörg Hertfelder, Johannes Oldenburg, Peter Dreßen, Stefan Brettner, Jürgen Homann, Gerhard J. Molderings, Kottarappat N Dileepan. Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation DiseasePLOS ONE 2015; 10(4): e0124912 doi: 10.1371/journal.pone.0124912
Lawrence B. Afrin, Dieter Pöhlau, Martin Raithel, Britta Haenisch, Franz L. Dumoulin, Juergen Homann, Uwe M. Mauer, Sabrina Harzer, Gerhard J. Molderings. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseasesBrain, Behavior, and Immunity 2015; 50: 314 doi: 10.1016/j.bbi.2015.07.002
Lawrence B. Afrin, Sally Self, Jeremiah Menk, John Lazarchick. Characterization of Mast Cell Activation SyndromeThe American Journal of the Medical Sciences 2017; 353(3): 207 doi: 10.1016/j.amjms.2016.12.013
B. Sido, J. Homann, H.-J. Hertfelder, T. Zienkiewicz, K.-P. Christians, P. Schablin, M. Mücke, G. J. Molderings. Chirurgische Eingriffe bei Patienten mit systemischer MastzellaktivierungserkrankungDer Chirurg 2019; 90(7): 548 doi: 10.1007/s00104-019-0935-z
Lawrence B. Afrin, Tania T. Dempsey, Lila S. Rosenthal, Shanda R. Dorff. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleedingJournal of Obstetrics and Gynaecology 2019; 39(5): 664 doi: 10.1080/01443615.2018.1550475
Gerhard J. Molderings, Britta Haenisch, Stefan Brettner, Jürgen Homann, Markus Menzen, Franz Ludwig Dumoulin, Jens Panse, Joseph Butterfield, Lawrence B. Afrin. Pharmacological treatment options for mast cell activation diseaseNaunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(7): 671 doi: 10.1007/s00210-016-1247-1
Gerhard J. Molderings. The genetic basis of mast cell activation disease - looking through a glass darklyCritical Reviews in Oncology/Hematology 2015; 93(2): 75 doi: 10.1016/j.critrevonc.2014.09.001
Lawrence B. Afrin, Alexander Khoruts. Mast Cell Activation Disease and Microbiotic InteractionsClinical Therapeutics 2015; 37(5): 941 doi: 10.1016/j.clinthera.2015.02.008
Lawrence B. Afrin. Mast cell activation disease and the modern epidemic of chronic inflammatory diseaseTranslational Research 2016; 174: 33 doi: 10.1016/j.trsl.2016.01.003
G. Simpson. Menstrual anaphylactoid reactions and presumed systemic mast cell activation syndromeInternal Medicine Journal 2016; 46(7): 858 doi: 10.1111/imj.13077
Craig Friesen, Meenal Singh, Vivekanand Singh, Jennifer V. Schurman. An observational study of headaches in children and adolescents with functional abdominal painMedicine 2018; 97(30): e11395 doi: 10.1097/MD.0000000000011395
Lawrence B. Afrin, Joseph H. Butterfield, Martin Raithel, Gerhard J. Molderings. Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic optionsAnnals of Medicine 2016; 48(3): 190 doi: 10.3109/07853890.2016.1161231
Lawrence B. Afrin. Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell DiseaseThe American Journal of the Medical Sciences 2014; 348(6): 460 doi: 10.1097/MAJ.0000000000000325
Gerhard J. Molderings. Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic featuresTranslational Research 2016; 174: 86 doi: 10.1016/j.trsl.2016.01.001
Theoharis C. Theoharides, Irene Tsilioni, Huali Ren. Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?Expert Review of Clinical Immunology 2019; 15(6): 639 doi: 10.1080/1744666X.2019.1596800
Anupam Aich, Lawrence Afrin, Kalpna Gupta. Mast Cell-Mediated Mechanisms of NociceptionInternational Journal of Molecular Sciences 2015; 16(12): 29069 doi: 10.3390/ijms161226151
Susan J. Allen, Paul L. Chazot, C. Jane Dixon. Can H2-receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case reportBritish Journal of Clinical Pharmacology 2018; 84(7): 1611 doi: 10.1111/bcp.13578